Value of Adding Dexmedetomidine in Endoscopic Ultrasound-Guided Celiac Plexus Neurolysis for Treatment of Pancreatic Cancer-Associated Pain
ConclusionThe addition of dexmedetomidine to bupivacaine 0.5% in EUS-CPN demonstrated beneficial effects as regards the degree and duration of pain relieve with negligible effect on the patient survival.
Source: Journal of Gastrointestinal Cancer - Category: Cancer & Oncology Source Type: research
More News: Alcoholism | Back Pain | Brain | Cancer | Cancer & Oncology | Gastroenterology | Laboratory Medicine | Neurology | Pain | Pancreas | Pancreatic Cancer | Statistics | Study | Ultrasound | Upper Endoscopy